Perkin Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.45 M
as on 17-11-2024
- Paid Up Capital ₹ 0.45 M
as on 17-11-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.96 Cr
as on 17-11-2024
- Satisfied Charges ₹ 3.50 Cr
as on 17-11-2024
- Revenue %
(FY 2023)
- Profit 0.98%
(FY 2023)
- Ebitda 5.41%
(FY 2023)
- Net Worth 21.56%
(FY 2023)
- Total Assets 14.67%
(FY 2023)
About Perkin Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.45 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹9.96 Cr. The company has closed loans amounting to ₹3.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rami Kesari, Pathapati Raju, Suryanarayana Dandu, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC054910
- Company No.
054910
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Perkin Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rami Kesari  | Director | 26-Jul-2007 | Current |
| Pathapati Raju | Director | 26-Jul-2007 | Current |
| Suryanarayana Dandu | Director | 28-Aug-2015 | Current |
| Kommoju Sekhar | Director | 12-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Perkin Laboratories.
Perkin Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.98% increase in profit. The company's net worth Soared by an impressive increase of 21.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Perkin Laboratories?
In 2023, Perkin Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Apr 2019 | ₹9.96 Cr | Open |
Axis Bank Limited Creation Date: 25 Feb 2008 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Perkin Laboratories?
Unlock and access historical data on people associated with Perkin Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Perkin Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perkin Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
